Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Associate Professor Peter Scanlon has been named as a winner at the prestigious Royal College of Physicians’ (RCP) Excellence in Patient Care Awards. 

Professor Scanlon, a Medical Ophthalmologist from Oxford University Hospitals who also has roles at Gloucestershire Hospitals NHS Foundation Trust and the University of Oxford, was one of three outstanding nominees for the ‘Contribution to the Profession’ award. The award is given to an RCP member or Fellow at any stage of their medical career who has shown excellence in their professional life so far.

Peter has been an amazing leader in developing and delivering diabetic retinopathy screening across the UK. We have been very fortunate in having Peter in Oxford spearheading this service. He has made a significant contribution to mentoring colleagues locally and nationally, as well as publishing seminal articles in the field.
- Professor Susan Downes

Professor Scanlon said: 'I am a great believer in effective team working, and I am very fortunate to work with some very conscientious hard-working individuals who really do put the patients’ needs first. When this level of commitment is harnessed with efficient team working it is easy to achieve as a team. I have been very fortunate to have the pleasure of working in two very effective Eye Units – in Oxford and Gloucestershire – and to have had the support of colleagues at Harris Manchester College and the Department of Clinical Neuroscience at the University of Oxford.'

Professor Scanlon has been Clinical Director of the English NHS Diabetic Eye Screening Programme since its inception in 2003. This has been a major contributor to diabetic retinopathy (DR) no longer being the leading cause of working age blindness, as well as leading to other positive health benefits for people needing ophthalmic care. He has helped improve processes for screening, assessment, and treatment across all of England to 2.3 million people with diabetes.

In 2018, Peter was awarded an Associate Professorship at the University of Oxford in ‘recognition of his contributions to research, teaching, and administration at Oxford and beyond’. He is a Tutor and Senior Research Fellow at Harris Manchester College in Oxford and, in four years, has given 34 regional, 18 national, and 60 international presentations with invitations to lecture in 12 countries.

More information about the awards can be found on the RCP website.

Similar stories

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.